CONTENTS
Editorials
Turn ride!. Mr. CAZAUBON ......................................... 6
Arteries
Peripheral arterial disease: S-scale CLAU ............... 9
Occlusive arterial disease of lower limbs. Health Authority ............ 12
Revascularization for critical lower limb ischemia - Prospective study about 20 cases in Dakar. P.S BA, A.G. CISS, O. DIARRA, A. NDIAYE, P.A. DIENG, G. CISSE, S.A. BEYE, M. NDIAYE..... 33
CREST syndrome revealed by a pulmonary hypertension: report of a case. M.B. NDIAYE, M. DIAO, M. BODIAN, A.D. KANE, A. MBAYE, F. KARMA, E.C.C. CISS, M. SARR, S.A. BA ........ 41
Cardiovascular Prevention
NaCl and hypertension: what if it was the Cl-Na and not who was responsible. F. A. ALLAERT ......... 45
Venous thromboembolic disease
Interests of the Doppler in the superficial venous thrombosis of the lower M. CAZAUBON, B. ANASTASIE, J.L. GILLET....................................... 48
Support for spontaneous venous thrombosis sharp as sitting at the confluence sapheno femoral or popliteal sapheno: VASCULAB. A.N. NONATO-CASTRO, E. MENDOZA, F. PASSARIELLO, E. RABE..............56
Dabigatran versus warfarin in patients with atrial fibrillation. A. GALA, C. BIRON-ANDREANI............................................65
Veins
Analysis of survey results DECIDES: pragmatic assessment of the properties of a grid for the diagnosis of chronic venous disease in general practice. M. CAZAUBON, J.C. KERIHUEL.................... 68
Sclerotherapy: my method. F. FERRARA...................................82
History of Medicine
1 / The men of exceptional that have advanced cardiovascular medicine.M. RAYNAUD (1834-1881) ........ 87
Membership form to the SFA ..........................................7
Announcement of the 63rd International Meeting of Angiology Francophones ......4-5 and 101-104
Announcement of Conference and events .................................. 90
Press Releases ...............................................95
Advertisers list ...............................................67
Subscriptions ..............................................100
Instructions to Authors .............................................Cover. 3